Not yet recruiting NCT06330974

Allergy, Asthma, and Atopic Eczema in Finland

— Observational Asthma Asthma in Children Allergy Rhinitis, Allergic

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied: The protocol lists: No intervention.
Who it may be relevant to: Registry conditions: Asthma, Asthma in Children, Allergy, Rhinitis, Allergic. Basic parameters: No limits · All.
What needs checking: Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place: Finland
Next step: Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Official title

Allergy, Asthma, and Atopic Eczema in Finland - A Nationwide Study on Prevalence, Comorbidities, Treatment and Economic Burden

The summary is available at --\> https://www.finnatopy.fi/summary

Detailed description

Aims and objectives ---\> https://www.finnatopy.fi/aims-and-objectives Methods ---\> https://www.finnatopy.fi/methods

Epidemiology of atopic diseases and allergic sensitization profiles in Finland [Time frame: 7 years]
Burden of atopic diseases (allergies, asthma, and atopic eczema) as well as comorbidities in Finland [Time frame: 7 years]
Evaluate and improve the current use of diagnostic tests for atopic diseases [Time frame: 7 years]
Use and effectiveness of allergen immunotherapy in real world setting [Time frame: 7 years]
Direct and indirect costs related to atopic diseases and comorbidities [Time frame: 7 years]

Inclusion/Exclusion Criteria ---> https://www.finnatopy.fi/methods

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Finland · 1 center

NCT: NCT06330974 · FinnATOPY